Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11530236
CD73 inhibitors
granted -
US 11529347
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 11524962
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
granted -
US 11518750
3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase
granted -
US 11518772
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 11512309
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11504364
Inhibitors of fibroblast activation protein
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted -
US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted -
US 11498905
Inhibitors of platelet function and methods for use of the same
granted -
US 11498928
Macrocyclic spiroethers as Mcl-1 inhibitors
granted -
US 11492351
MTA-cooperative PRMT5 inhibitors
granted -
US 11492349
IRAK inhibitors and method for making and using
granted -
US 11485760
Inhibitors of CRISPR-Cas9
granted -
US 11485738
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 11485739
Compounds useful as inhibitors of ATR kinase
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted -
US 11479551
MTA-cooperative PRMT5 inhibitors
granted -
US 11479543
Heterocyclic RIP1 kinase inhibitors
granted -
US 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 11465972
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
granted -
US 11466017
Heterocyclic inhibitors of PTPN11
granted -
US 11464774
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
granted